Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Corporate News
Corporate Performance
Executive Activities
Government
Military
Email
Stock Market
Legal
Internet Media, Content & Design
Table bottom

Infectious Disease
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a...
CNW Group, 8:28pm ET



ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a...
PR Newswire, 7:53pm ET

LONDON, November 22, 2017 /PRNewswire/ -- ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug...
PR Newswire Europe, 7:43pm ET

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has approved JULUCA®, the first, complete, single-pill, two-drug regimen for the treatment of human...
PR Newswire, 6:13pm ET

Dr. John C. Lantis II, Professor of Surgery at the Icahn School of Medicine in New York City, will present an overview of the latest scientific and clinical results on the use of fish skin in wound healing at the annual Desert Foot conference....
GlobeNewswire, 6:03pm ET

The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in...
PR Newswire, 2:08pm ET

For the second time in three months, the Centers for Disease Control and Prevention is warning people who might have consumed contaminated raw milk and milk products to visit their doctor. People who bought and drank raw milk from a company...
PR Newswire, 1:53pm ET

Public health challenges, such as disease outbreaks and substance abuse problems, do not recognize jurisdictional boundaries. "Staff Sharing Arrangements for Local Public Health," a report released today by the Center for State and Local...
PR Newswire, 1:08pm ET

--Under the present system, countries where average income is $2.76 per day are considered middle-income. The new Global Fund Executive Director should end the policy that transitions out such countries, even when HIV epidemics are still on the...
BusinessWire, 12:33pm ET

Janssen Biotech, Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for DARZALEX® (daratumumab). This application seeks to expand the current indication,...
PR Newswire, 11:43am ET

The message simply shows that diet and diabetes cannot be separated. With the rise of non-communicable diseases such as diabetes and cancer, calls to eat health foods have been growing. "Policies that increase availability of nutritious and...
All Africa Global Media, 11:38am ET

DUBLIN, November 21, 2017 /PRNewswire/ -- The "Glucose Monitoring Devices - Global Strategic Business Report" [https://www.researchandmarkets.com/research/njlmns/glucose] report has been added to Research and Markets' offering....
PR Newswire Europe, 11:23am ET

subscriber-premium"> Bella Hadid felt "so much stronger" during this year's Victoria's Secret Fashion Show. The 21-year-old model graced the runway for the lingerie giant's extravaganza, which took place at the Mercedes Benz...
University Wire, 11:08am ET

CORNWALL, N.Y., UNITED STATES, November 21, 2017 /EINPresswire.com/...
EIN News, 10:13am ET

People with type 1 diabetes can lead long, active lives if they carefully monitor their glucose, make the needed lifestyle changes, and adhere to the treatment plan. Diabetes is a chronic, lifelong condition that affects your body's...
All Africa Global Media, 10:13am ET

The Cystic Fibrosis Foundation has announced the recipients of its second annual Impact Grants. The Impact Grants Program provides funding to unique projects by and for people with cystic fibrosis (CF) and their family...
BusinessWire, 10:08am ET

Janssen-Cilag International NV today announced the submission of a Type II variation application to the European Medicines Agency (EMA), for the immunotherapy DARZALEX(R) (daratumumab). The application seeks to broaden the...
BusinessWire, 9:48am ET

The Lupus Research Alliance celebrated the 2017 Breaking through Lupus Gala to shed a spotlight on breakthroughs from the previous years, and the importance of lupus research to deliver discoveries to come. With the generous support of nearly 700...
PR Newswire, 9:43am ET

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management...
Globe Newswire, 9:23am ET

Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter...
GlobeNewswire, 9:23am ET

1-20 of 201
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.